Remedium Lifecare Ltd

Remedium Life Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Remedium Lifecare Ltd

₹ 0.45 4.65%
11 Mar - close price
remlife.com BSE: 539561
About

Incorporated in 1988, Remedium Lifecare Ltd is in the business of trading in Advanced Pharmaceutical Intermediates and other pharma products

Key Points

Business Overview:[1]
Company does trading and sale of API intermediates (KSMs & CRMs) and various other raw materials used in API trading to innovator and generic pharmaceutical players in Domestic and International markets

Website BSE
  • Market Cap ₹ 39.7 Cr.
  • Current Price ₹ 0.45
  • High / Low ₹ 6.97 / 0.40
  • Stock P/E 18.6
  • Book Value ₹ 1.19
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE 4.85 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Stock is trading at 0.38 times its book value

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 1.13%
  • Earnings include an other income of Rs.10.8 Cr.
  • Company has high debtors of 695 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Services Services Commercial Services & Supplies Trading & Distributors

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Jun 2025 Sep 2025
264.32 113.37 111.06
264.78 111.50 103.68
Operating Profit -0.46 1.87 7.38
OPM % -0.17% 1.65% 6.65%
0.66 3.48 3.25
Interest 1.59 -0.36 0.19
Depreciation 0.01 0.00 0.00
Profit before tax -1.40 5.71 10.44
Tax % 45.71% 18.56% 17.34%
-2.05 4.65 8.62
EPS in Rs -0.02 0.05 0.10
Raw PDF
Upcoming result date: 30 March 2026

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025
405
404
Operating Profit 1
OPM % 0%
11
Interest 8
Depreciation 0
Profit before tax 4
Tax % 51%
2
EPS in Rs 0.02
Dividend Payout % 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: -17%
3 Years: -64%
1 Year: -93%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Sep 2025
Equity Capital 40 88
Reserves 4 17
1,141 1,088
535 430
Total Liabilities 1,720 1,623
0 6
CWIP 0 0
Investments 0 0
1,720 1,617
Total Assets 1,720 1,623

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025
-1,135
0
1,136
Net Cash Flow 1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025
Debtor Days 695
Inventory Days 247
Days Payable 459
Cash Conversion Cycle 483
Working Capital Days 38
ROCE %

Insights

In beta
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Export Value (Actual Inflows/FOB)
INR Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Revenue from Sale of Products (Trading)
INR Lakhs
Permanent Employee Count
Number ・Standalone data
Revenue from Electroplating Services
INR Lakhs ・Standalone data
Trade Receivables Turnover
Days

Shareholding Pattern

Numbers in percentages

35 Recently
Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.13% 1.13% 1.13%
0.00% 0.04% 0.08% 0.04% 0.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.70%
98.88% 98.84% 98.81% 98.86% 98.85% 98.89% 98.89% 98.89% 98.89% 98.87% 98.87% 97.17%
No. of Shareholders 7051,7303,9883,85915,58726,46467,40473,6371,10,4221,13,5431,14,1191,11,269

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports